Header Logo

Connection

Donald Jensen to Cytochrome P-450 CYP3A Inhibitors

Back to Details
This is a "connection" page, showing publications Donald Jensen has written about Cytochrome P-450 CYP3A Inhibitors.
Donald Jensen
Connection Strength
0.032
Cytochrome P-450 CYP3A Inhibitors
  1. Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirin. J Hepatol. 2015 Feb; 62(2):294-302.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.